LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma

Gastric adenocarcinoma (GAC) is inherently resistant or becomes resistant to therapy, leading to a poor prognosis. Mounting evidence suggests that lncRNAs can be used as predictive markers and therapeutic targets in the right context. In this study, we determined the role of lncRNA-PVT1 in GAC along...

Full description

Bibliographic Details
Main Authors: Yuan Li, Shumei Song, Melissa Pool Pizzi, Guangchun Han, Ailing W. Scott, Jiankang Jin, Yan Xu, Ying Wang, Longfei Huo, Lang Ma, Christopher Vellano, Xiaolin Luo, Robert MacLeod, Linghua Wang, Zhenning Wang, Jaffer A. Ajani
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
LncRNA
PVT1
antisense oligonucleotides
gastric adenocarcinoma and therapeutic target
Online Access:https://www.mdpi.com/2072-6694/12/10/2995

Internet

https://www.mdpi.com/2072-6694/12/10/2995

Similar Items